Caris Life Sciences CAI Ratios (2024-2026)

NASDAQ CAI
$21.67 -1.37 (-5.95%)
As of: Nov 16, 2026 · 11:37 AM EST
Reported Financials

Caris Life Sciences Quarterly Ratios

Periods 10 quarters
Latest Sep 2026

Caris Life Sciences reported a gross margin of 66.20% and a net margin of 5.54% for the quarter ended Sep 2026. These financial ratios cover 10 quarters of results from Jun 2024 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Profitability
Gross Margin 37.54%43.70%54.42%47.19%62.67%68.03%75.43%65.39%68.10%66.20%
EBT Margin -66.15%-66.65%-28.44%-84.84%-39.58%11.22%27.98%-0.30%-0.23%6.13%
EBIT Margin -66.98%-59.87%-28.52%-47.93%-9.92%15.05%30.19%2.44%10.21%7.01%
EBITDA Margin -53.65%-47.74%-20.07%-40.49%-2.11%18.45%31.86%6.02%12.79%9.53%
Operating Margin -66.98%-59.87%-28.52%-47.93%-9.92%15.05%30.19%2.44%10.21%7.01%
Net Margin -89.74%-90.92%-47.68%-105.07%-285.12%11.22%27.98%-0.24%-0.24%5.54%
FCF Margin -70.12%-31.72%-28.14%3.25%25.52%13.55%10.42%2.43%-14.42%
Efficiency
Inventory AverageInventory Avg. 44.96M56.46M69.96M100.04M131.08M
Assets AverageAssets Avg. 969.81M1,055.12M1,144.03M1,196.00M1,242.62M
Equity AverageEquity Avg. -2,252.27M-2,400.77M-2,470.40M-2,549.35M-1,073.48M465.63M527.84M585.40M592.61M615.61M
Invested CapitalInvested Cap. -2,119.31M826.61M854.82M956.30M975.07M984.89M1,032.75M
Asset Utilization RatioAsset Util. 0.670.770.790.830.84
Leverage & Solvency
Interest Coverage RatioInterest Cover -4.90-4.41-2.79-4.53-0.942.427.790.412.922.09
Debt Ratio 1.100.390.380.340.330.320.31
Times Interest Earned -4.90-4.41-2.79-4.53-0.942.427.790.412.922.09
Valuation
Price to EarningsP/E 47.9091.42
Price to SalesP/S 3.2513.155.565.575.098.38
Price to BookP/B 3.8317.847.818.528.5113.73
Enterprise Value 1,011.94M7,776.61M3,711.11M4,230.33M4,242.51M8,014.78M
EV to EBIT 82.2639.0427.6857.28
EV to EBITDA 46.0929.6923.5648.20
Market Capitalization 1,734.64M8,533.62M4,511.21M5,053.79M5,035.63M8,782.16M
Price to FCFP/FCF 67.4440.9440.62303.78
EV to FCF 55.4834.2734.23277.23
EV to CFO 44.6328.7125.1795.54
Return Ratios
Return on Sales [ROS]ROS -66.98%-59.87%-28.52%-47.93%-9.92%15.05%30.19%2.44%10.21%7.01%
Return on Capital Employed [ROCE]ROCE -9.09%4.86%10.83%15.26%12.91%
Return on Invested Capital [ROIC]ROIC 11.22%15.64%13.66%
Return on Assets [ROA]ROA -19.23%-6.41%3.00%8.76%7.70%
Return on Equity [ROE]ROE -40.06%-12.81%5.87%17.67%15.54%

Caris Life Sciences Ratios API

Pull Caris Life Sciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CAI&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY